Industry Payments Common for Physician Peer Reviewers of Top Journals
Peer reviewers in this study received $64.18 million in general payments between 2020 and 2022
Related Articles
Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial
Stereotactic body radiotherapy (SBRT) without androgen deprivation therapy (ADT) has lower rates of incontinence and sexual dysfunction, with a small trade-off in bowel bother, compared…
Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial
Stereotactic body radiotherapy (SBRT) without androgen deprivation therapy (ADT) has lower rates of incontinence and sexual dysfunction, with a small trade-off in bowel bother, compared…
The Impact of Social Deprivation on Anterior Urethral Stricture Recurrence After Urethroplasty: A Trauma and Urologic Reconstructive Network of Surgeons Analysis | Journal of Urology
Purpose:Several factors influence recurrence after urethral stricture repair. The impact of socioeconomic factors on stricture recurrence after urethroplasty is poorly understood. This study aims to…
Chad Ellimoottil, MD, on the future for AI in urology
“These types of technologies can really make office urology much more efficient, which I think is very, very promising and one of the most promising…
European Urology Today – Uroweb
European Urology Today (EUT) is the official newsletter of the EAU. It is produced five times a year, informing members on announcements, news about the…
Stories of single-port surgery (and cricket)
Our final episode of the year! And we end with a very seasonal celebration of single-port surgery and the Boxing Day Test with Australia playing…
What’s changing with reimbursement for cystoscopy packs
“As a result of the changes and the programmed phase-in of the changes, the cystoscopy code total RVU for the office setting will be 8%…
Registration – American Urological Association
Registration for the 2025 AUA Innovation Nexus Conference is now open! As you plan to attend this groundbreaking event, please review these key details. For…
FDA approves subcutaneous nivolumab for solid tumors, including RCC
The approval is supported by data from the phase 3 CheckMate-67T trial.
Top 10 kidney stone stories in 2024
As the year comes to a close, we revisit some of this year’s top content on kidney stone management.